ARCHIVES

NCI Cooperative Group Clinical Trials Approved

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Cost Of Cancer:$40 Billion In 1980, Now Probably Between $50-80 Billion; “The Tip Of The Iceberg”

February 25, 1983

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014